Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE

    Sep 6, 2024, 09:05 AM by
    Full story
  • Biotech’s Secret to Surviving Economic Challenges? It’s All in the Data & AI

    Sep 6, 2024, 01:00 AM by User Not Found
    Bio-IT World | Data has always been crucial in the life sciences industry, but in today's fiercely competitive landscape, its significance has skyrocketed. Amidst dwindling funding and mounting market pressures, biopharmaceutical companies need to better harness the power of information to design and accelerate clinical trials and timelines.
    Full story
  • InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling

    Sep 5, 2024, 07:29 AM by
    InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. Veronika Musatova, Head of IRT development team, comments on the new version, “As a result of the update, B cells model reflects the current views on the processes and sequence of this cell type development maintaining a balance between the model detail and complexity.”
    Full story
  • VedaBio Appoints Dr. G. Brett Robb as Senior Scientific Director and Head of CRISPR Science

    Sep 5, 2024, 07:29 AM by
    VedaBio Appoints Accomplished Leader, Dr. G. Brett Robb, as Senior Scientific Director and Head of CRISPR Science to Drive Platform Expansion and Industrialization
    Full story
  • Sapio Sciences Advances The World's First AI-Powered Lab Assistant

    Sep 4, 2024, 08:05 AM by
    Sapio Sciences today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently. Sapio ELaiN is also now generally available after a successful beta launch in November 2023.
    Full story
  • Enzene appoints new site Lead for Flagship US continuous bioManufacturing facility

    Sep 4, 2024, 08:05 AM by
    Full story
  • Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination

    Sep 3, 2024, 08:50 AM by
    Phreesia and the American Academy of Pediatrics (AAP) have joined forces to increase measles, mumps and rubella (MMR) immunization by reaching parents and caregivers of eligible or soon-to-be eligible children at the point of care. The collaboration comes as immunization rates have dipped in some communities, pointing to a need to improve access to the vaccines that can help keep children healthy.
    Full story
  • Amgen’s AI Futures: Digital Twins, Unstructured Data, Human Review

    Sep 3, 2024, 01:00 AM by User Not Found
    Bio-IT World | Jerry Murry, senior vice president, process and development, at Amgen, gave the plenary presentation at CHI’s Bioprocessing Summit last month. With an eighteen-year tenure at Amgen—and experience at Merck and Pfizer before that—Murry has seen nearly two decades of advances in the world of bioprocessing and manufacturing.
    Full story
  • NIH Launches Native Collective Research Effort Focused on Overdose

    Sep 3, 2024, 01:00 AM by User Not Found
    Bio-IT World | In August, the National Institutes of Health (NIH) has launched the Native Collective Research Effort to Enhance Wellness (N CREW) Program, an effort support Native American communities to lead public health research to address overdose, substance use, and pain, including related factors such as mental health and wellness. The planned program funding totals approximately $268 million over seven years.
    Full story
  • Indica Labs and Paige Forge Strategic Partnership to Expand Integrated AI for Anatomic Pathology Labs

    Aug 30, 2024, 07:33 AM by
    Indica Labs and Paige have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP®.
    Full story
  • LabWare Inc. and Mettler-Toledo International Inc. Boost Laboratory Productivity through New Plug-and-Play Software Integration

    Aug 30, 2024, 07:33 AM by
    METTLER TOLEDO is a global leader in precision instruments and services. We are renowned for innovation and quality across laboratory, process analytics, industrial, product inspection, and retailing applications. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries, and we have a direct presence in approximately 40 countries. For more information, please visit www.mt.com. LabWare is recognized as the global leader of Laboratory Information Management Systems (LIMS) and instrument integration software products. The company’s Enterprise Laboratory Platform combines the award-winning LabWare LIMS™ and LabWare ELN™, which enables its clients to optimize compliance, improve quality, increase productivity, and reduce costs. LabWare is a full-service informatics provider offering software, professional implementation and validation services, training, and world-class technical support to ensure customers get the maximum value from their LabWare products. Founded in 1987, the company is headquartered in Wilmington, Delaware with offices throughout the world to support customer installations in over 125 countries. For more information, visit the LabWare website at www.labware.com.
    Full story
  • PathAI's AISightⓇ Dx Image Management System is CE Marked for Primary Diagnosis

    Aug 29, 2024, 08:12 AM by
    PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISightⓇ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis. The CE mark paves the way for the company's expansion in the European diagnostic pathology market, enhancing pathologists' interpretations and driving efficiencies and quality improvements within anatomic pathology laboratories.
    Full story
  • Follow the Money: AI-Powered Cell Therapies, Cancer Risk Assessment, More

    Aug 29, 2024, 01:00 AM by User Not Found
    Bio-IT World | Outpace Bio will advance multiple programmed T cell product candidates to early clinical proof-of-concept for the treatment of solid tumors; Foresight Diagnostics plans to accelerate the clinical development and commercialization of their cancer recurrence testing platform, PhasED-Seq; PreciseDx plan to expand commercialization efforts for PreciseBreast risk assessment, an AI-Powered test used to assess early-stage invasive breast cancer risk; and more.
    Full story
  • Dovetail Genomics, Goenomics GmbH Partnership, Danaher Acquires Genedata, Andelyn Biosciences License Agreement With Broad Institute, More

    Aug 28, 2024, 01:00 AM by User Not Found
    Bio-IT World |Dovetail Genomics has formed a partnership with Goenomics GmbH to deliver an enhanced genome assembly service with the fastest turnaround time and most complete annotation available in the industry; Genedata has been acquired by Danaher; Andelyn Biosciences has entered into a License Agreement with the Broad Institute of MIT and Harvard to expand its AAV Curator Platform offering to include MyoAAV plasmids; and more.
    Full story
  • Panel Explores the Rapidly Evolving Field of Genetic Medicines

    Aug 27, 2024, 05:00 AM by User Not Found
    Bio-IT World | In a panel discussion at last week’s Bioprocessing Summit, four leaders in genetic medicine shared insights into the rapidly evolving world of gene editing and its potential to revolutionize the treatment of complex diseases. In a panel discussion at last week’s Bioprocessing Summit, four leaders in genetic medicine shared insights into the rapidly evolving world of gene editing and its potential to revolutionize the treatment of complex diseases.
    Full story
  • The Art of Building Techbio Teams

    Aug 23, 2024, 14:21 PM by User Not Found
    Bio-IT World | The biotech industry is experiencing a significant shift as technology and biology converge. This intersection, often called Techbio, is opening up new possibilities for addressing health and environmental challenges.
    Full story
  • Alta Stomatology Introduces Scientific Platforms to Advance Oral Disease Drug Development

    Aug 22, 2024, 08:09 AM by
    Full story
  • International Consortium to Revolutionize Viral Vector Manufacturing

    Aug 21, 2024, 08:05 AM by
    Abselion has announced the collaboration of leading biotechnology companies and research organizations in UK and Canada to develop next-generation cell platform for viral vector production.
    Full story
  • First Clinical Trial of ‘Paradoxical Intervention’ for Cancer to Begin Soon

    Aug 21, 2024, 01:00 AM by User Not Found
    Bio-IT World | Cancer cells are “not like superheroes that have no vulnerabilities." Most current therapies try to block the signaling to prevent cancer’s uncontrolled division, but inevitably tumor cells resist the blockage and become far less responsive to subsequent therapy.
    Full story
  • Biopharma PEG Expands Multi-Arm PEG Product Line for Medical and Biopharma Applications

    Aug 20, 2024, 08:17 AM by
    Full story
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28 (current)
  • 29
  • 30
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy